Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

TSX:WEED - Post by User

Canopy Growth Corp > Reddit Chatter

<< Previous

Bullboard Posts

Next >>

Comment by TinTorontoon Feb 10, 2021 9:22am

113 Views

Post# 32523376

RE:RE:Reddit Chatter

Citron has been shorting this forever, Lefts nightmare continues into the cannabis sector - It was bound to happen. When Cowen speaks the market pays attention, new ATHs this year.

WestCoast78 wrote: Ahem....mr carter raises est to $21 cad. Ahhhhhhh that's nice.

TinToronto wrote:
Reddit chatter pushes cannabis stocks higher

Feb. 10, 2021 8:17 AM ETTilray, Inc. (TLRY)By: Jonathan M Block, SA News Editor21 Comments

Cannabis stocks are surging this morning as the Reddit forum WallStreetBets turns it's attention to the sector.

One WSB user wrote that Tilray (NASDAQ:TLRY) and Aphria (NASDAQ:APHA), which are up 80% and 61%, respectively, in the past 5 days, still have more room to run, Reuters reported.

Canopy Growth (NYSE:CGC) shares are up 6% premarket following a bullish note from Benchmark's Mark Hickey who wrote "revenue growth should be significant in Canada over the next several quarters."

Not all analysts feel strongly about Canopy as Stifel analyst W. Andrew Carter mains his sell rating as the company's "revenue growth targets will prove ambitious."

Carter, however, raised his price target to C$21 from C$18.

Here's how some other pot stocks are performing premarket:

Pot stocks are higher this morning: Aurora Cannabis (NYSE:ACB) +13.9%; Hexo (NYSE:HEXO) +10.7%; Tilray (TLRY) +23.4%; Canopy Growth (CGC) +6%; Cronos Group (NASDAQ:CRON) +11.3%; OrganiGram Holdings (NASDAQ:OGI) +31.4%, and AdvisorShares Pure Cannabis ETF (NYSEARCA:YOLO) +8.3%.